SAM
VIR icon

Sectoral Asset Management’s Vir Biotechnology VIR Stock Holding History

Sectoral Asset Management’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-4,200
Closed -$107K – 118
2022
Q2 		$107K Buy
+4,200
New +$98.1K 0.02% 110
2022
Q1 		– Sell
-6,000
Closed -$251K – 117
2021
Q4 		$251K Buy
+6,000
New +$235K 0.04% 104
2020
Q3 		– Sell
-7,100
Closed -$291K – 175
2020
Q2 		$291K Buy
+7,100
New +$238K 0.03% 159

Other funds holding VIR

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Sectoral Asset Management's VIR Position: Q3 2022 in Review

Sectoral Asset Management sold out of Vir Biotechnology (VIR) in Q3 2022, closing a stake of 4,200 shares — an estimated $107K sold.

Sectoral Asset Management first reported a position in VIR in Q2 2020 and held it in 3 quarters. The position peaked at $291K in Q2 2020. 221 funds tracked by Wall St. Rank hold VIR as of Q3 2022.

  • Sectoral Asset Management reported no remaining Vir Biotechnology position as of Q3 2022 after selling out during the quarter.
  • Sectoral Asset Management sold 4,200 Vir Biotechnology shares in Q3 2022, an estimated $107K.
  • Sectoral Asset Management first reported a position in Vir Biotechnology in Q2 2020 and held it in 3 quarters.
  • Sectoral Asset Management's Vir Biotechnology position peaked at $291K in Q2 2020.
  • 221 funds tracked by Wall St. Rank held Vir Biotechnology as of Q3 2022.

Based on Sectoral Asset Management's 13F filing for Q3 2022, filed 10 Nov 2022.